These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides. Huang R; Liu J; Sharp JS Anal Chem; 2013 Jun; 85(12):5787-95. PubMed ID: 23659663 [TBL] [Abstract][Full Text] [Related]
8. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644 [TBL] [Abstract][Full Text] [Related]
9. Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. Staples GO; Shi X; Zaia J J Biol Chem; 2010 Jun; 285(24):18336-43. PubMed ID: 20363743 [TBL] [Abstract][Full Text] [Related]
10. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chen J; Jones CL; Liu J Chem Biol; 2007 Sep; 14(9):986-93. PubMed ID: 17884631 [TBL] [Abstract][Full Text] [Related]
11. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. Kuberan B; Lech M; Zhang L; Wu ZL; Beeler DL; Rosenberg RD J Am Chem Soc; 2002 Jul; 124(29):8707-18. PubMed ID: 12121115 [TBL] [Abstract][Full Text] [Related]
12. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131 [TBL] [Abstract][Full Text] [Related]
13. De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides. Huang R; Zong C; Venot A; Chiu Y; Zhou D; Boons GJ; Sharp JS Anal Chem; 2016 May; 88(10):5299-307. PubMed ID: 27087275 [TBL] [Abstract][Full Text] [Related]
14. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase. Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655 [TBL] [Abstract][Full Text] [Related]
15. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860 [TBL] [Abstract][Full Text] [Related]
16. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin. Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795 [TBL] [Abstract][Full Text] [Related]
17. The 3- Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484 [TBL] [Abstract][Full Text] [Related]